Commerzbank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,000	Closed	-$398K	–	997
2019 Q2	$398K	Buy	+15,000	New	+$4.99M	﹤0.01%	788
2019 Q1	–	Sell	-37,700	Closed	-$411K	–	967
2018 Q4	$411K	Hold	37,700	–	–	﹤0.01%	699
2018 Q3	$391K	Buy	37,700 +17,800	+89%	+$6.77M	﹤0.01%	732
2018 Q2	$244K	Buy	+19,900	New	+$6.22M	﹤0.01%	809

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Commerzbank Aktiengesellschaft's REGN Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 6.1% in Q2 2026, selling an estimated $22.5K and leaving 506 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #297.

Commerzbank Aktiengesellschaft first reported a position in REGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $33.9M in Q2 2015. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Commerzbank Aktiengesellschaft held 506 shares of Regeneron Pharmaceuticals worth $316K as of Q2 2026.
Commerzbank Aktiengesellschaft sold 33 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $22.5K.
Regeneron Pharmaceuticals made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #297 holding.
Commerzbank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
Commerzbank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $33.9M in Q2 2015.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.